AZELAPRAG BIOAGE - AN OVERVIEW

The biotech sought to bear this mechanism out in STRIDES, a mid-phase, randomized, double-blinded and placebo-managed demo that evaluated the efficacy and safety of azelaprag—with and with no Eli Lilly’s blockbuster incretin procedure tirzepatide—in greater than 200 men and women with weight problems.To complicate this further, tirzepatide it